Trialmed Sp. z o.o.

At Trialmed Sp. z o.o. in Piotrkow Trybunalski, clinical research in digestive system diseases focuses on Crohn’s disease and ulcerative colitis. These studies are designed to evaluate new treatment options, help maintain remission, and improve long-term disease control for people living with chronic inflammatory bowel conditions.

• Studies in Crohn’s disease and ulcerative colitis exploring better ways to reduce inflammation and sustain clinical response
• Research on moderately to severely active Crohn’s disease and moderate to severe ulcerative colitis with a focus on treatment effectiveness and safety
• Trials assessing new therapies intended to improve symptom control and support long-term digestive health

This therapeutic area reflects the site’s strong gastroenterology profile, with multiple studies aimed at advancing care for patients with chronic intestinal inflammation.

Research in immune system diseases at this site includes rheumatoid arthritis and inflammatory bowel conditions such as Crohn’s disease. The trials are centered on testing therapies that may better control immune-driven inflammation, relieve symptoms, and improve patient function over time.

• Trials in rheumatoid arthritis evaluating whether new treatments can match or improve established care
• Studies in Crohn’s disease looking at options to maintain response and reduce active inflammation
• Research focused on the effectiveness and safety of therapies for chronic immune-mediated disease

The immune system portfolio highlights efforts to develop more effective, better-tolerated approaches for long-term inflammatory disease management.

In the area of cardiovascular diseases, the site is studying heart failure, including heart failure with reduced ejection fraction and forms with mildly reduced or preserved ejection fraction. These trials aim to assess new therapies that may improve symptoms, physical function, and overall disease outcomes.

• Studies in heart failure testing whether investigational treatments can improve day-to-day functioning and symptom burden
• Research in heart failure with reduced ejection fraction and related subtypes focused on treatment benefit and safety
• Trials examining therapies for heart failure linked with systemic inflammation

This cardiovascular research broadens the site’s clinical scope beyond digestive care and supports development of better options for people with complex cardiac disease.

Clinical trials in nutritional and metabolic diseases at Trialmed Sp. z o.o. include type 2 diabetes, obesity, and overweight with related metabolic risk. The main goal is to evaluate therapies that may improve blood sugar control, support weight reduction, and address the overlap between excess body weight and diabetes.

• Studies in type 2 diabetes assessing improved glycaemic control and treatment convenience
• Trials in overweight and obesity examining body weight reduction as a treatment outcome
• Research involving overweight and obesity and type 2 diabetes to address combined metabolic disease

This field focuses on practical treatment advances that may help patients manage both metabolic health and long-term cardiovascular risk.

The site also contributes to respiratory tract diseases research through studies in asthma. These trials are evaluating new approaches for people whose asthma remains only partially controlled, with the aim of improving symptom stability and reducing loss of control.

• Research in asthma focused on maintaining control and lowering the risk of worsening symptoms
• Trials testing whether new therapies can improve outcomes for adults with persistent respiratory inflammation
• Studies designed to support better management of chronic airway disease

The respiratory portfolio adds another important dimension to the site’s clinical research, with attention on therapies that may offer better control for chronic airway conditions.